GE's AI clearances surge

GE HealthCare said its count of Food and Drug Administration-cleared AI tools rose to 85 over the past year, up from 58. (fool.com) Chief Executive Officer Peter Arduini gave the figure on the company’s April 22, 2026 earnings call. GE HealthCare had previously said in October 2023 that it led the Food and Drug Administration’s list with 58 AI-enabled device authorizations. (fool.com) (gehealthcare.com) In medical devices, an AI clearance means regulators have authorized a product for marketing in the United States. The Food and Drug Administration says its AI-enabled medical device list is meant to show which products have been authorized and to give providers and patients more transparency. (fda.gov) Most of these products are not chatbots. They are imaging, monitoring, and workflow tools that flag patterns in scans, improve image quality, or help clinicians sort urgent cases faster. (fda.gov) (gehealthcare.com) GE HealthCare has been building that portfolio for years. In July 2025, the company said it had reached 100 listed U.S. authorizations and had topped the Food and Drug Administration’s list for a fourth straight year. (gehealthcare.com) The broader market is also getting more crowded. The Food and Drug Administration’s current AI-enabled device page says the list is updated as new products are authorized, extending a category that already expanded sharply in prior agency updates. (fda.gov 1) (fda.gov 2) A higher clearance count does not tell hospitals whether a tool saves time or improves outcomes in daily use. GE HealthCare’s own product language ties its AI systems to image enhancement, operational efficiency, and reduced cognitive load for care teams, which are the claims customers still have to test in their own workflows. (gehealthcare.com 1) (gehealthcare.com 2) The company is still adding to the tally in 2026. On April 2, GE HealthCare said the Food and Drug Administration cleared True Definition DL, a deep-learning computed tomography imaging tool designed to improve detail and suppress artifacts. (gehealthcare.com) The near-term readout is simple: GE HealthCare is accumulating U.S. clearances quickly, and the harder next step is proving those cleared tools change work on hospital floors and in radiology suites. (fool.com) (fda.gov)